Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01233778 · ClinicalTrials.gov registry record · NA

Canola Oil Multicentre Intervention Trial (COMIT)

A NA study of Cardiovascular Disease, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT01233778 is a NA study of Cardiovascular Disease that has completed, run by Penn State University. The registered enrollment target is 43 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01233778, a NA study of Cardiovascular Disease, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The objectives of this study are to examine how the consumption of treatment oils (including canola oil, DHA enriched canola-oil, high oleic acid canola oil, flax oil, and safflower oil) influence endothelial function, inflammation, oxidation, body composition, and plasma lipoprotein characterization.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Safflower Oil
  • DIETARY_SUPPLEMENT Canola Oil
  • DIETARY_SUPPLEMENT High Oleic Acid + DHA Canola Oil
  • DIETARY_SUPPLEMENT High Oleic Acid Canola Oil
  • DIETARY_SUPPLEMENT Flax Oil

Study Locations (1)

Pennsylvania

  • Penn State University - University Park

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2010-10
Est. Completion 2012-04
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT01233778

The ClinicalTrials.gov registry entry for NCT01233778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 5 interventions - of which Safflower Oil is the first listed.

NCT01233778 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01233778 about?

NCT01233778 is a clinical study titled "Canola Oil Multicentre Intervention Trial (COMIT)". The objectives of this study are to examine how the consumption of treatment oils (including canola oil, DHA enriched canola-oil, high oleic acid canola oil, flax oil, and safflower oil) influence endothelial function, inflammation, oxidation, body composition, and plasma lipoprotein characterizatio...

What is the current status of trial NCT01233778?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2010-10. Estimated completion is 2012-04.

What conditions does trial NCT01233778 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT01233778?

The interventions under investigation include: Safflower Oil (DIETARY_SUPPLEMENT), Canola Oil (DIETARY_SUPPLEMENT), High Oleic Acid + DHA Canola Oil (DIETARY_SUPPLEMENT), High Oleic Acid Canola Oil (DIETARY_SUPPLEMENT), Flax Oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01233778?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01233778 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.